Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.

Nguyen KA, Li L, Lu D, Yazdanparast A, Wang L, Kreutz RP, Whipple EC, Schleyer TK.

Eur J Clin Pharmacol. 2018 May 22. doi: 10.1007/s00228-018-2482-9. [Epub ahead of print] Review.

PMID:
29785580
2.

Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.

Krüger K, Leppkes N, Gehrke-Beck S, Herrmann W, Algharably EA, Kreutz R, Heintze C, Filler I.

Br J Gen Pract. 2018 Jun;68(671):e401-e407. doi: 10.3399/bjgp18X696173. Epub 2018 Apr 23.

PMID:
29686133
3.

Treatment Thresholds and Targets in Hypertension: Different Readings of the Same Evidence?

Tsioufis C, Thomopoulos C, Kreutz R.

Hypertension. 2018 Jun;71(6):966-968. doi: 10.1161/HYPERTENSIONAHA.118.10815. Epub 2018 Apr 23. No abstract available.

PMID:
29686019
4.

Pain, Fear of Falling, and Functional Performance Among Nursing Home Residents: A Longitudinal Study.

Kalinowski S, Dräger D, Kuhnert R, Kreutz R, Budnick A.

West J Nurs Res. 2018 Mar 1:193945918759958. doi: 10.1177/0193945918759958. [Epub ahead of print]

PMID:
29577826
5.

[Rivaroxaban for thrombosis prophylaxis in extensive hip and knee operations. Subanalysis of the German cohort (XAMOS-DE) of non-interventional study XAMOS].

Mouret P, Kreutz R, Deilmann K, Dihlmann A, Holberg G, Haas S.

MMW Fortschr Med. 2017 Oct;159(Suppl 6):26-33. doi: 10.1007/s15006-017-0083-z. Epub 2017 Oct 5. German.

PMID:
29557090
6.

Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography.

Maatman BT, Schmeisser G, Kreutz RP.

J Diabetes Res. 2018 Feb 4;2018:4543065. doi: 10.1155/2018/4543065. eCollection 2018.

7.
8.

Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.

Empey PE, Stevenson JM, Tuteja S, Weitzel KW, Angiolillo DJ, Beitelshees AL, Coons JC, Duarte JD, Franchi F, Jeng LJB, Johnson JA, Kreutz RP, Limdi NA, Maloney KA, Owusu Obeng A, Peterson JF, Petry N, Pratt VM, Rollini F, Scott SA, Skaar TC, Vesely MR, Stouffer GA, Wilke RA, Cavallari LH, Lee CR; IGNITE Network.

Clin Pharmacol Ther. 2017 Dec 26. doi: 10.1002/cpt.1006. [Epub ahead of print]

PMID:
29280137
9.

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Cavallari LH, Lee CR, Beitelshees AL, Cooper-DeHoff RM, Duarte JD, Voora D, Kimmel SE, McDonough CW, Gong Y, Dave CV, Pratt VM, Alestock TD, Anderson RD, Alsip J, Ardati AK, Brott BC, Brown L, Chumnumwat S, Clare-Salzler MJ, Coons JC, Denny JC, Dillon C, Elsey AR, Hamadeh IS, Harada S, Hillegass WB, Hines L, Horenstein RB, Howell LA, Jeng LJB, Kelemen MD, Lee YM, Magvanjav O, Montasser M, Nelson DR, Nutescu EA, Nwaba DC, Pakyz RE, Palmer K, Peterson JF, Pollin TI, Quinn AH, Robinson SW, Schub J, Skaar TC, Smith DM, Sriramoju VB, Starostik P, Stys TP, Stevenson JM, Varunok N, Vesely MR, Wake DT, Weck KE, Weitzel KW, Wilke RA, Willig J, Zhao RY, Kreutz RP, Stouffer GA, Empey PE, Limdi NA, Shuldiner AR, Winterstein AG, Johnson JA; IGNITE Network.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):181-191. doi: 10.1016/j.jcin.2017.07.022. Epub 2017 Nov 1.

PMID:
29102571
10.

Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.

Volpe M, Tocci G, de la Sierra A, Kreutz R, Laurent S, Manolis AJ, Tsioufis K.

High Blood Press Cardiovasc Prev. 2017 Dec;24(4):463-472. doi: 10.1007/s40292-017-0239-7. Epub 2017 Oct 31.

11.

Drug-induced kidney injury: A large case series from the Berlin Case-Control Surveillance Study
.

Douros A, Bronder E, Klimpel A, Erley C, Garbe E, Kreutz R.

Clin Nephrol. 2018 Jan;89 (2018)(1):18-26. doi: 10.5414/CN109212.

PMID:
29035197
12.

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.

Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C, Burton R, Cardoso M, Colom J, Duprez D, Gmel G, Gual A, Kraus L, Kreutz R, Liira H, Manthey J, Møller L, Okruhlica Ľ, Roerecke M, Scafato E, Schulte B, Segura-Garcia L, Shield KD, Sierra C, Vyshinskiy K, Wojnar M, Zarco J.

BMC Med. 2017 Sep 28;15(1):173. doi: 10.1186/s12916-017-0934-1.

13.

Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.

Kreutz R, Scholze J, Douros A.

Curr Vasc Pharmacol. 2018 Jan 26;16(2):197-203. doi: 10.2174/1570161115666170821155555.

PMID:
28828980
14.

Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.

Kreutz R, Persson PB, Kubitza D, Thelen K, Heitmeier S, Schwers S, Becka M, Hemmrich M.

J Thromb Haemost. 2017 Oct;15(10):2017-2028. doi: 10.1111/jth.13801. Epub 2017 Sep 14.

PMID:
28805299
15.

Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.

Wadelius M, Eriksson N, Kreutz R, Bondon-Guitton E, Ibañez L, Carvajal A, Lucena MI, Sancho Ponce E, Molokhia M, Martin J, Axelsson T, Kohnke H, Yue QY, Magnusson PKE, Bengtsson M, Hallberg P; EuDAC.

Clin Pharmacol Ther. 2018 May;103(5):843-853. doi: 10.1002/cpt.805. Epub 2017 Sep 28.

16.

Small molecules as therapy for uveitis: a selected perspective of new and developing agents.

Pleyer U, Algharably EA, Feist E, Kreutz R.

Expert Opin Pharmacother. 2017 Sep;18(13):1311-1323. doi: 10.1080/14656566.2017.1361408. Epub 2017 Aug 7. Review.

PMID:
28750572
17.

The impact of α-Lipoic acid on cell viability and expression of nephrin and ZNF580 in normal human podocytes.

Leppert U, Gillespie A, Orphal M, Böhme K, Plum C, Nagorsen K, Berkholz J, Kreutz R, Eisenreich A.

Eur J Pharmacol. 2017 Sep 5;810:1-8. doi: 10.1016/j.ejphar.2017.06.013. Epub 2017 Jun 10.

PMID:
28606850
18.

Uromodulin associates with cardiorenal function in patients with hypertension and cardiovascular disease.

Algharably EAH, Bolbrinker J, Lezius S, Reibis R, Wegscheider K, Völler H, Kreutz R.

J Hypertens. 2017 Oct;35(10):2053-2058. doi: 10.1097/HJH.0000000000001432.

PMID:
28598953
19.

Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24.

PMID:
28544026
20.

European guidelines on lifestyle changes for management of hypertension : Awareness and implementation of recommendations among German and European physicians.

Bolbrinker J, Zaidi Touis L, Gohlke H, Weisser B, Kreutz R.

Herz. 2018 Jun;43(4):352-358. doi: 10.1007/s00059-017-4575-0. Epub 2017 May 22.

PMID:
28534177
21.

Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study.

Turpie AGG, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Ageno W.

Thromb Res. 2017 Jul;155:23-27. doi: 10.1016/j.thromres.2017.04.001. Epub 2017 Apr 13.

PMID:
28477534
22.

Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy.

Abdel-Hady Algharably E, Beige J, Kreutz R, Bolbrinker J.

Pharmacogenomics J. 2018 Apr;18(2):227-231. doi: 10.1038/tpj.2017.14. Epub 2017 Apr 18.

PMID:
28418009
23.

Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenoson.

Berlacher M, Mastouri R, Philips S, Skaar TC, Kreutz RP.

Pharmacogenomics. 2017 Apr;18(6):523-529. doi: 10.2217/pgs-2016-0178. Epub 2017 Mar 30.

PMID:
28358597
24.

Pain management intervention targeting nursing staff and general practitioners: Pain intensity, consequences and clinical relevance for nursing home residents.

Dräger D, Budnick A, Kuhnert R, Kalinowski S, Könner F, Kreutz R.

Geriatr Gerontol Int. 2017 Oct;17(10):1534-1543. doi: 10.1111/ggi.12924. Epub 2016 Dec 9.

PMID:
27935182
25.

Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection.

Rekers NV, Flaig TM, Mallat MJK, Spruyt-Gerritse MJ, Zandbergen M, Anholts JDH, Bajema IM, Clahsen-van Groningen MC, Yang J, de Fijter JW, Claas FHJ, Brakemeier S, Lachmann N, Kreutz R, de Heer E, Budde K, Bolbrinker J, Eikmans M.

Transplantation. 2017 Sep;101(9):2017-2025. doi: 10.1097/TP.0000000000001584.

PMID:
27926596
26.

Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.

Kreutz RP, Schmeisser G, Maatman B, Schaffter A, Sinha A, von der Lohe E, Breall JA.

Thromb Haemost. 2017 Jan 26;117(2):426-428. doi: 10.1160/TH16-10-0496. Epub 2016 Nov 3. No abstract available.

PMID:
27808346
27.

Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System.

Flaig T, Douros A, Bronder E, Klimpel A, Kreutz R, Garbe E.

J Clin Pharm Ther. 2016 Dec;41(6):718-721. doi: 10.1111/jcpt.12456. Epub 2016 Sep 27.

PMID:
27670839
28.

Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.

Langer S, Kreutz R, Eisenreich A.

J Nephrol. 2016 Dec;29(6):765-773. Epub 2016 Jan 5.

PMID:
26733332
29.

The importance of protein binding for the in vitro-in vivo extrapolation (IVIVE)-example of ibuprofen, a highly protein-bound substance.

Mielke H, Di Consiglio E, Kreutz R, Partosch F, Testai E, Gundert-Remy U.

Arch Toxicol. 2017 Apr;91(4):1663-1670. doi: 10.1007/s00204-016-1863-z. Epub 2016 Oct 21.

PMID:
27770144
30.

Statin intolerance - a question of definition.

Algharably EA, Filler I, Rosenfeld S, Grabowski K, Kreutz R.

Expert Opin Drug Saf. 2017 Jan;16(1):55-63. Epub 2016 Sep 27. Review.

PMID:
27645111
31.

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention.

Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA.

Clin Pharmacol. 2016 Jun 3;8:45-50. doi: 10.2147/CPAA.S98790. eCollection 2016.

32.

Physician Contacts and Their Influence on the Appropriateness of Pain Medication in Nursing Home Residents: A Cross-Sectional Study.

Flaig TM, Budnick A, Kuhnert R, Kreutz R, Dräger D.

J Am Med Dir Assoc. 2016 Sep 1;17(9):834-8. doi: 10.1016/j.jamda.2016.05.014. Epub 2016 Jun 24.

PMID:
27349624
33.

The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.

Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, Vogtländer K, Turpie AG.

Vasc Health Risk Manag. 2016 May 18;12:209-18. doi: 10.2147/VHRM.S100293. eCollection 2016.

34.

[Pharmacovigilance in Germany : It is about time].

Douros A, Schaefer C, Kreutz R, Garbe E.

Internist (Berl). 2016 Jun;57(6):616-23. doi: 10.1007/s00108-016-0068-0. Review. German.

PMID:
27224991
35.

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.

Hallberg P, Eriksson N, Ibañez L, Bondon-Guitton E, Kreutz R, Carvajal A, Lucena MI, Ponce ES, Molokhia M, Martin J, Axelsson T, Yue QY, Magnusson PK, Wadelius M; EuDAC collaborators.

Lancet Diabetes Endocrinol. 2016 Jun;4(6):507-16. doi: 10.1016/S2213-8587(16)00113-3. Epub 2016 May 3.

PMID:
27157822
36.

Real life studies and good clinical practice - Authors' reply.

Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG.

Lancet Haematol. 2016 Apr;3(4):e160-1. doi: 10.1016/S2352-3026(16)00027-2. No abstract available.

PMID:
27063973
37.

Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes.

Eisenreich A, Langer S, Herlan L, Kreutz R.

J Hypertens. 2016 Feb;34(2):323-31. doi: 10.1097/HJH.0000000000000799.

PMID:
26867059
38.

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.

Eadon MT, Desta Z, Levy KD, Decker BS, Pierson RC, Pratt VM, Callaghan JT, Rosenman MB, Carpenter JS, Holmes AM, McDonald CA, Benson EA, Patil AS, Vuppalanchi R, Gufford BT, Dave N, Robarge JD, Hyder MA, Haas DM, Kreutz RP, Dexter PR, Skaar TC, Flockhart DA.

Clin Pharmacol Ther. 2016 Jul;100(1):63-6. doi: 10.1002/cpt.347. Epub 2016 Mar 31. Review.

39.

Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.

Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J.

Int J Mol Sci. 2016 Jan 15;17(1). pii: E114. doi: 10.3390/ijms17010114.

40.

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.

Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG.

Lancet Haematol. 2016 Jan;3(1):e12-21. doi: 10.1016/S2352-3026(15)00257-4. Epub 2015 Dec 8.

PMID:
26765643
41.

Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.

Pulido-Olmo H, García-Prieto CF, Álvarez-Llamas G, Barderas MG, Vivanco F, Aranguez I, Somoza B, Segura J, Kreutz R, Fernández-Alfonso MS, Ruilope LM, Ruiz-Hurtado G.

Clin Sci (Lond). 2016 Apr 1;130(7):525-38. doi: 10.1042/CS20150517. Epub 2016 Jan 5.

PMID:
26733721
42.

Genetic low nephron number hypertension is associated with altered expression of key components of the renin-angiotensin system during nephrogenesis.

Faensen AL, von Trebra MW, Freese F, Kreutz R, Bamberg C, Hinkson L, Rothermund L.

J Perinat Med. 2016 Aug 1;44(6):705-9. doi: 10.1515/jpm-2015-0159.

PMID:
26677883
43.

Validation of a Modified German Version of the Brief Pain Inventory for Use in Nursing Home Residents with Chronic Pain.

Budnick A, Kuhnert R, Könner F, Kalinowski S, Kreutz R, Dräger D.

J Pain. 2016 Feb;17(2):248-56. doi: 10.1016/j.jpain.2015.10.016. Epub 2015 Nov 18.

PMID:
26598064
44.

Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies.

Wallukat G, Müller J, Haberland A, Berg S, Schulz A, Freyse EJ, Vetter R, Salzsieder E, Kreutz R, Schimke I.

Atherosclerosis. 2016 Jan;244:44-7. doi: 10.1016/j.atherosclerosis.2015.11.001. Epub 2015 Nov 10.

PMID:
26584137
45.

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions.

Kreutz R, Haas S, Holberg G, Lassen MR, Mantovani LG, Schmidt A, Turpie AG.

Br J Clin Pharmacol. 2016 Apr;81(4):724-34. doi: 10.1111/bcp.12836. Epub 2016 Feb 12.

46.

AMPD1 polymorphism and response to regadenoson.

Saab R, Zouk AN, Mastouri R, Skaar TC, Philips S, Kreutz RP.

Pharmacogenomics. 2015 Nov;16(16):1807-15. doi: 10.2217/pgs.15.116. Epub 2015 Nov 10.

47.

Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice.

Lassen MR, Haas S, Kreutz R, Mantovani LG, Holberg G, Turpie AG.

Clin Appl Thromb Hemost. 2016 Mar;22(2):138-46. doi: 10.1177/1076029615607303. Epub 2015 Sep 25.

PMID:
26408640
48.

Falls Self-Efficacy in German Nursing Home Residents: Assessment of Validity and Determination of a Cutoff Point.

Könner F, Kuhnert R, Kalinowski S, Dräger D, Kreutz R, Wulff I, Budnick A.

Res Gerontol Nurs. 2016 May 1;9(3):134-44. doi: 10.3928/19404921-20150827-33. Epub 2015 Sep 1.

PMID:
26366582
49.

A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy.

Huber M, Lezius S, Reibis R, Treszl A, Kujawinska D, Jakob S, Wegscheider K, Völler H, Kreutz R.

Int J Mol Sci. 2015 Jul 30;16(8):17456-68. doi: 10.3390/ijms160817456.

50.

Nonpharmacologic Pain Management Interventions in German Nursing Homes: A Cluster Randomized Trial.

Kalinowski S, Budnick A, Kuhnert R, Könner F, Kissel-Kröll A, Kreutz R, Dräger D.

Pain Manag Nurs. 2015 Aug;16(4):464-74. doi: 10.1016/j.pmn.2014.09.002.

PMID:
26256216

Supplemental Content

Loading ...
Support Center